Latest Insider Transactions at Intuitive Surgical Inc (ISRG)
This section provides a real-time view of insider transactions for Intuitive Surgical Inc (ISRG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTUITIVE SURGICAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTUITIVE SURGICAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 26
2024
|
Marshall Mohr Executive VP Global Business S |
SELL
Payment of exercise price or tax liability
|
Direct |
867
-3.13%
|
$337,263
$389.77 P/Share
|
|
Feb 26
2024
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
1,710
+5.81%
|
-
|
|
Feb 26
2024
|
Jamie Samath |
SELL
Payment of exercise price or tax liability
|
Direct |
459
-5.6%
|
$178,551
$389.77 P/Share
|
|
Feb 26
2024
|
Jamie Samath |
BUY
Exercise of conversion of derivative security
|
Direct |
1,284
+13.54%
|
-
|
|
Feb 26
2024
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
867
-0.4%
|
$337,263
$389.77 P/Share
|
|
Feb 26
2024
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,710
+0.78%
|
-
|
|
Feb 26
2024
|
Fredrik Widman VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
218
-6.61%
|
$84,802
$389.77 P/Share
|
|
Feb 26
2024
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
609
+15.59%
|
-
|
|
Feb 26
2024
|
Gary S Guthart CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,536
-11.17%
|
$597,504
$389.77 P/Share
|
|
Feb 26
2024
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,030
+18.05%
|
-
|
|
Feb 26
2024
|
Henry L Charlton SVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
384
-1.7%
|
$149,376
$389.77 P/Share
|
|
Feb 26
2024
|
Henry L Charlton SVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
1,284
+5.37%
|
-
|
|
Feb 16
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
32
-4.32%
|
$12,096
$378.29 P/Share
|
|
Feb 15
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
30
-3.89%
|
$11,460
$382.03 P/Share
|
|
Feb 15
2024
|
Keith R Leonard Director |
SELL
Bona fide gift
|
Direct |
2,547
-71.07%
|
-
|
|
Feb 14
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
30
-3.75%
|
$11,400
$380.09 P/Share
|
|
Feb 13
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
30
-3.61%
|
$11,250
$375.5 P/Share
|
|
Feb 12
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
30
-3.48%
|
$11,580
$386.09 P/Share
|
|
Feb 12
2024
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
481
-61.75%
|
$185,666
$386.09 P/Share
|
|
Feb 10
2024
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
357
-31.43%
|
$138,516
$388.22 P/Share
|
|
Feb 10
2024
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
838
+42.45%
|
-
|
|
Feb 10
2024
|
Gary Loeb General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
129
-6.37%
|
$50,052
$388.22 P/Share
|
|
Feb 10
2024
|
Gary Loeb General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
315
+13.47%
|
-
|
|
Feb 10
2024
|
David J. Rosa President |
SELL
Payment of exercise price or tax liability
|
Direct |
729
-0.34%
|
$282,852
$388.22 P/Share
|
|
Feb 10
2024
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
1,437
+0.66%
|
-
|
|
Feb 10
2024
|
Brian Edward Miller EVP & Chief Digital Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
487
-4.74%
|
$188,956
$388.22 P/Share
|
|
Feb 10
2024
|
Brian Edward Miller EVP & Chief Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,317
+11.37%
|
-
|
|
Feb 10
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Payment of exercise price or tax liability
|
Direct |
425
-33.05%
|
$164,900
$388.22 P/Share
|
|
Feb 10
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
BUY
Exercise of conversion of derivative security
|
Direct |
838
+39.45%
|
-
|
|
Feb 10
2024
|
Gary S Guthart CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,335
-11.07%
|
$517,980
$388.22 P/Share
|
|
Feb 10
2024
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,634
+17.93%
|
-
|
|
Feb 10
2024
|
Jamie Samath |
SELL
Payment of exercise price or tax liability
|
Direct |
401
-5.48%
|
$155,588
$388.22 P/Share
|
|
Feb 10
2024
|
Jamie Samath |
BUY
Exercise of conversion of derivative security
|
Direct |
1,078
+12.85%
|
-
|
|
Feb 10
2024
|
Marshall Mohr Executive VP Global Business S |
SELL
Payment of exercise price or tax liability
|
Direct |
1,085
-4.0%
|
$420,980
$388.22 P/Share
|
|
Feb 10
2024
|
Marshall Mohr Executive VP Global Business S |
BUY
Exercise of conversion of derivative security
|
Direct |
2,873
+9.58%
|
-
|
|
Feb 10
2024
|
Fredrik Widman VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
222
-7.63%
|
$86,136
$388.22 P/Share
|
|
Feb 10
2024
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
568
+16.33%
|
-
|
|
Feb 10
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
SELL
Payment of exercise price or tax liability
|
Direct |
316
-3.8%
|
$122,608
$388.22 P/Share
|
|
Feb 10
2024
|
Robert De Santis EVP & Chief Strategy & Corp Op |
BUY
Exercise of conversion of derivative security
|
Direct |
958
+10.32%
|
-
|
|
Feb 10
2024
|
Henry L Charlton SVP & Chief Commercial and Mkt |
SELL
Payment of exercise price or tax liability
|
Direct |
338
-1.56%
|
$131,144
$388.22 P/Share
|
|
Feb 10
2024
|
Henry L Charlton SVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
1,078
+4.73%
|
-
|
|
Feb 07
2024
|
David J. Rosa President |
SELL
Open market or private sale
|
Direct |
80,710
-7.88%
|
$31,396,190
$389.28 P/Share
|
|
Feb 07
2024
|
David J. Rosa President |
BUY
Exercise of conversion of derivative security
|
Direct |
140,850
+12.03%
|
$7,465,050
$53.16 P/Share
|
|
Feb 01
2024
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
39
-8.01%
|
$14,742
$378.41 P/Share
|
|
Jan 29
2024
|
Gary S Guthart CEO |
SELL
Open market or private sale
|
Indirect |
4,960
-8.31%
|
$1,855,040
$374.41 P/Share
|
|
Jan 29
2024
|
Gary S Guthart CEO |
SELL
Open market or private sale
|
Direct |
24,325
-72.07%
|
$9,146,200
$376.06 P/Share
|
|
Jan 29
2024
|
Gary S Guthart CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
33,750
+50.0%
|
$1,721,250
$51.02 P/Share
|
|
Jan 26
2024
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,318
-91.26%
|
$1,597,660
$370.15 P/Share
|
|
Jan 26
2024
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,318
+47.71%
|
$777,240
$180.41 P/Share
|
|
Jan 26
2024
|
Amal M Johnson |
SELL
Open market or private sale
|
Direct |
6,696
-36.39%
|
$2,477,520
$370.08 P/Share
|